Coronary artery disease: Complex coronary disease in the post-SYNTAX era.
Should patients with high-risk coronary artery disease be treated with CABG or receive drug-eluting stents? The SYNTAX trial aimed to define the optimal revascularization strategy for patients with previously untreated three-vessel and/or left main coronary artery disease.